Rankings
▼
Calendar
LNTH Q2 2016 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena
LNTH
Lantheus Holdings, Inc.
$5B
Q2 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$78M
Gross Profit
$36M
45.9% margin
Operating Income
$14M
18.2% margin
Net Income
$7M
9.4% margin
EPS (Diluted)
$0.24
QoQ Revenue Growth
+2.0%
Cash Flow
Operating Cash Flow
$18M
Free Cash Flow
$17M
Stock-Based Comp.
$585,000
Balance Sheet
Total Assets
$259M
Total Liabilities
$426M
Stockholders' Equity
-$166M
Cash & Equivalents
$55M
Revenue Segments
US Segment
$65M
84%
International Segment
$13M
16%
← FY 2016
All Quarters
Q3 2016 →